1. Practical guidelines for therapeutic drug monitoring of anticancer tyrosine kinase inhibitors: focus on the pharmacokinetic targets.;Yu;Clin. Pharmacokinet.,2014
2. Food and Drug Administration Center for Drug Evaluation and Research Alectinib Clinical Pharmacology and Biopharmaceutics Review http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf 2016
3. Food and Drug Administration Center for Drug Evaluation and Research Ceritinib Clinical Pharmacology and Biopharmaceutics Review http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205755Orig1s000ClinPharmR.pdf 2014
4. Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency Ceritinib European Public Assessment report. 44 2015
5. European Medicines Agency Committee for Medicinal Products For Human Use (CHMP) Crizotinib European Public Assessment Report http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002489/WC500134761.pdf 2012